OPTIMIND PHARMA CORP. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.005 CAD | 0.00% |
|
0.00% | 0.00% |
| 01-26 | Optimind Pharma Reaches Agreement On Debenture Conversion | MT |
| 01-10 | Optimind Pharma Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended November 30, 2023 | CI |
Quotes 5-day view
Delayed Quote Canadian Securities Exchange| 2024-05-14 | |
|---|---|
| Last | 0.005 $ |
| Volume | 20 000 |
| Change | +∞% |
| Opening | 0.01 |
| High | 0.01 |
| Low | 0.01 |
Performance
| 6 months | -50.00% | ||
| 1 year | -88.89% |
Volumes
marketsDaily volume
20 000
Estimated daily volume
20 000
Avg. Volume 20 sessions
9 333
Daily volume ratio
2.14
Avg. Volume 20 sessions CAD
46.67
Avg. Volume 20 sessions USD
34.26
Record volume 1
2 070 770
Record volume 2
430 017
Record volume 3
300 000
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (CAD)
490 631
Capitalization (USD)
360 221
Net sales (CAD)
170 113
Net sales (USD)
124 897
Free-Float
92.31 %
Free-Float capitalization (CAD)
539 691
Free-Float capitalization (USD)
396 241
Average Daily Capital Traded
0.01%
Highs and lows
1 week
0.01
0.01
1 month
0.010.01
Current year
0.010.01
1 year
0.010.04
3 years
0.010.20
5 years
0.010.20
10 years
0.010.20
Indicators
Moving average 20 days
0.00
Moving average 50 days
0.01
Moving average 100 days
0.01
Price spread / (MMA20)
-4.00%
Price spread / (MMA50)
+82.00%
Price spread / (MMA100)
+16.00%
RSI 9 days
49.49
RSI 14 days
47.99
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| 0.00% | 0.00% | 0.00% | -88.89% | 360K | ||
| +1.04% | +6.26% | +9.42% | +28.99% | 114B | ||
| +1.48% | +1.48% | +11.84% | +32.33% | 104B | ||
| -2.55% | -1.58% | -14.15% | -14.20% | 22.41B | ||
| -1.45% | -2.58% | -1.05% | -8.28% | 22.28B | ||
| +0.74% | +1.90% | -5.29% | -28.18% | 19.07B | ||
| -1.49% | -1.04% | -38.29% | -34.78% | 18B | ||
| +1.06% | +2.50% | -4.16% | -27.65% | 17.89B | ||
| +0.27% | +1.88% | +7.99% | +50.84% | 14.28B | ||
| -1.02% | -0.70% | +36.24% | -11.91% | 12.55B | ||
| -2.61% | -0.79% | -24.95% | -37.92% | 8.45B | ||
| -1.17% | +13.73% | +18.74% | +54.55% | 8.21B | ||
| -3.43% | -3.57% | -52.50% | -69.89% | 7.76B | ||
| -0.59% | -0.47% | -0.71% | +33.86% | 7.72B | ||
| -2.98% | -16.46% | +260.02% | +171.86% | 7.62B | ||
| -1.37% | -9.02% | -3.83% | +29.73% | 7.04B | ||
| Average | -0.88% | +0.13% | +12.46% | +5.03% | ||
| Weighted average by Cap. | +0.22% | +1.50% | +8.06% | +16.49% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | 0.00% | ||
| 2023 | -83.33% | ||
| 2022 | -80.00% |
- Stock Market
- Equities
- OMND Stock
- Quotes Optimind Pharma Corp.